Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for DXCM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2002. Start Trial.
Date Value
December 31, 2025 1.441B
December 31, 2024 989.50M
December 31, 2023 748.50M
December 31, 2022 669.50M
December 31, 2021 442.50M
December 31, 2020 475.60M
December 31, 2019 314.50M
December 31, 2018 123.20M
December 31, 2017 92.00M
December 31, 2016 56.20M
December 31, 2015 48.00M
December 31, 2014 23.60M
Date Value
December 31, 2013 2.40M
December 31, 2012 -33.10M
December 31, 2011 -30.13M
December 31, 2010 -42.68M
December 31, 2009 -39.39M
December 31, 2008 -37.45M
December 31, 2007 -33.21M
December 31, 2006 -43.73M
December 31, 2005 -22.55M
December 31, 2004 -12.43M
December 31, 2003 -9.462M
December 31, 2002 -7.027M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Abbott Laboratories 9.566B
Insulet Corp. 569.30M
Baxter International, Inc. 845.00M
Globus Medical, Inc. 753.45M
Stryker Corp. 5.044B